Search for: "LTS Lohmann Therapie-Systeme AG"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
7 Apr 2013, 9:37 pm
.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
3 Feb 2014, 9:51 pm
.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical, LTD; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
29 Jun 2014, 9:21 pm
.; Novartis AG; Novartis Pharma AG; LTS Lohmann Therapie-Systeme AG • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
7 Sep 2014, 8:35 pm
.; UCB Pharma GmbH; LTS Lohmann Therapie-Systeme AG • Defendants: Watson Laboratories Inc. [read post]
5 Apr 2017, 9:08 am
Appellants Novartis AGand LTS Lohmann Therapie-Systeme AG (together,“Novartis”) contest numerous aspects of the Final WrittenDecisions, including the PTAB’s conclusion that priorjudicial opinions did not control its inquiry and thePTAB’s factual findings in support of its obviousnessconclusion. [read post]
11 Jan 2011, 11:08 am
LTS Lohmann Therapie Systeme AG and Schwartz Pharma Ltd and Commissioner of Patents [2010] AAT 809. [read post]
25 Aug 2009, 1:30 pm
Organon decision, LTS Lohmann Therapie-Systeme AG and Schwarz Pharma Limted [2009] APO 16. [read post]
11 Jan 2011, 11:07 pm
General Steve Burrill makes predictions for the biotech industry in 25th annual report (Patent Docs) Australia: ‘Innovation’ patents in Australia – AMI innovation patent and US investment (IPBiz) Australia: Extension of patent term for pharmaceuticals in Australia: AAT decision in LTS Lohmann Therapie Systeme AG and Schwarz Pharma Ltd and Commissioner of Patents (Patent Baristas) US: CAFC : Single embodiment commercial success: In re… [read post]
26 Aug 2009, 6:12 am
The Corporate Gold Rush to Patent Your Genes’ perpetuates popular misperceptions surrounding gene patents (Holman's Biotech IP Blog) Australian pharmaceutical patent term extension for patches and implants: N V Organon; LTS Lohmann Therapie-Systeme AG and Schwarz Pharma Limited (Patent Baristas) China: Obama Administration and compulsory licensing in China (China Hearsay) China: Forty-two of Simcere’s generic drugs enter… [read post]
